Muna Tuna

EY US Market Access, Pricing and Reimbursement Leader, Ernst & Young LLP

Advisor to life sciences companies for over two decades. Leader for defining and executing market access strategies. Articulating product value beyond the clinical to manage margin pressures.

Muna has been advising life sciences companies for over 20 years. She joins from another Big Four firm where she helped clients define and execute market access strategies and stand up cross-functional market access capabilities to drive long-term value. Most recently, she has supported the launch of rare disease and cell and gene therapy assets across immunology, CNS, Type 1 diabetes, and heme.

Our latest thinking

    Contact Muna